BIOMAT Database Logo BIOMAT Database Logo

Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties. 2004

Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Université Joseph Fourier de Grenoble, Laboratoire d'Etudes Dynamiques et Structurales de la Sélectivité, Bât. C Chimie, 301 rue de la chimie, Domaine Universitaire, 38400 Saint-Martin d'Hères (Grenoble), France.

A series of aromatic sulfonamides incorporating indane moieties were prepared starting from commercially available 1- and 2-indanamine, and their activity as inhibitors of two carbonic anhydrase (CA, EC 4.2.1.1) isozymes, hCA I and II was studied. The new sulfonamides incorporating acetamido, 4-chloro-benzoyl, valproyl, tetra-, and pentafluorobenzoyl moieties acted as very potent inhibitors of the slow red blood cell isozyme hCA I (K(i)s in the range of 1.6-8.5 nM), which usually has a lower affinity for such inhibitors, as compared to isozyme II. Some derivatives also showed excellent hCA II inhibitory properties (K(i)s in the range of 2.3-12 nM), but the anticonvulsant activity of these sulfonamides was rather low as compared to that of other sulfonamide/sulfamate CA inhibitors, such as methazolamide. Furthermore, the 2-amino/acetamido-indane-5-sulfonic acids prepared during this work also showed interesting CA inhibitory properties, with inhibition constants in the range of 43-89 nM against the two isozymes, being among the most potent sulfonic acid CA inhibitors reported so far.

UI MeSH Term Description Entries
D007189 Indans Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES. Indanones
D002257 Carbonic Anhydrase Inhibitors A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. Carbonate Dehydratase Inhibitor,Carbonate Dehydratase Inhibitors,Carbonic Anhydrase Inhibitor,Carboxyanhydrase Inhibitor,Carboxyanhydrase Inhibitors,Anhydrase Inhibitor, Carbonic,Dehydratase Inhibitor, Carbonate,Inhibitor, Carbonate Dehydratase,Inhibitor, Carbonic Anhydrase,Inhibitor, Carboxyanhydrase,Inhibitors, Carbonate Dehydratase,Inhibitors, Carbonic Anhydrase,Inhibitors, Carboxyanhydrase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D024401 Carbonic Anhydrase I A cytosolic carbonic anhydrase isoenzyme primarily expressed in ERYTHROCYTES, vascular endothelial cells, and the gastrointestinal mucosa. EC 4.2.1.- CA I Hiroshima-1,Carbonic Anhydrase B,Carbonic Anhydrase I Hiroshima-1,Carbonic Anhydrase Isoenzyme B,Anhydrase B, Carbonic,CA I Hiroshima 1,Carbonic Anhydrase I Hiroshima 1

Related Publications

Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
January 2002, Journal of medicinal chemistry,
Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity.
May 2004, Bioorganic & medicinal chemistry,
Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating phthaloyl and phthalimido moieties.
January 2001, Drug design and discovery,
Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Carbonic anhydrase inhibitors: design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes.
June 2008, Bioorganic & medicinal chemistry letters,
Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
November 2015, Bioorganic & medicinal chemistry,
Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Carbonic Anhydrase Inhibition with Sulfonamides Incorporating Pyrazole- and Pyridazinecarboxamide Moieties Provides Examples of Isoform-Selective Inhibitors.
November 2021, Molecules (Basel, Switzerland),
Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Carbonic anhydrase inhibitors. Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydrase.
June 2013, Bioorganic & medicinal chemistry letters,
Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
June 2005, Bioorganic & medicinal chemistry letters,
Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
March 2005, Journal of medicinal chemistry,
Celine Chazalette, and Bernard Masereel, and Stéphanie Rolin, and Anne Thiry, and Andrea Scozzafava, and Alessio Innocenti, and Claudiu T Supuran
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
November 2004, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!